Clinical Trial Update: Phase 2/3 Oxabact Study [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial of Oxabact for primary hyperoxaluria has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperoxaluria

Drugs mentioned

• Oxabact

Snippet

Sponsor: OxThera | Conditions: Primary Hyperoxaluria | Phase 2, Phase 3 | Status: COMPLETED